MB "Biofulas" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 178,929 |
| - |
| 29,422 |
| 29,422 |
| - |
| 24.59 |
| 16.44 |
| 29,421 |
| 9,912 |
| 4,800 |
| 34,533 |
| 0.14 |
| 0.34 |
| - |
| - |
| 16.44 |
| 29,422 |
| 2023 |
|---|
| 340,547 |
| - |
| 3,164 |
| 2,689 |
| - |
| 56.90 |
| 0.79 |
| 32,110 |
| 10,769 |
| 10,875 |
| 32,004 |
| 0.06 |
| 0.34 |
| - |
| - |
| 0.97 |
| 3,295 |
| 2024 |
|---|
| 133,540 |
| - |
| -47,507 |
| -47,507 |
| - |
| 12.24 |
| -35.58 |
| -15,398 |
| 22,959 |
| 6,545 |
| 1,016 |
| -0.16 |
| -1.49 |
| - |
| - |
| -35.29 |
| -47,130 |
| 2024 |
|---|
| 133,540 |
| - |
| -47,507 |
| -47,507 |
| - |
| 12.24 |
| -35.58 |
| -15,398 |
| 22,959 |
| 6,545 |
| 1,016 |
| -0.16 |
| -1.49 |
| - |
| - |
| -35.29 |
| -47,130 |
Turnover (€)
2024
Turnover (€)
133,540 €-61 % *
Sales per employee (€)
-Profit before tax (€)
-47,507 €-1,601 % *
Net Profit (€)
-47,507 €-1,867 % *
Profit per employee (€)
-Total profitability (%)
12.24 %-78.49 % *
Net profitability (%)
-35.58 %-4,603.80 % *
Equity (€)
-15,398 €-148 % *
Amounts Payable And Liabilities (€)
22,959 €113 % *
Non-current Assets (€)
6,545 €-40 % *
CurrentAssets (€)
1,016 €-97 % *
Working capital requirement
-0.16 -366.67 % *
Debt-to-equity ratio
-1.49 -538.24 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-35.29 %-3,738.14 % *
EBIT (€)
-47,130 €-1,530 % *
